Ardent Health, Inc.
15.01-0.08 (-0.53%)
Oct 29, 4:00:02 PM EDT · NYSE · ARDT · USD
Key Stats
Market Cap
2.15BP/E (TTM)
7.94Basic EPS (TTM)
1.89Dividend Yield
0%Recent Filings
10-Q
Q2 FY2025 results
Ardent Health's Q2 revenue climbed 11.9% year-over-year to $1.65B, fueled by 10.2% higher net patient service revenue per adjusted admission from supplemental programs and reimbursement gains, while adjusted admissions edged up 1.6% on 6.6% admission growth. Operating income hit $122.0M, up sharply from $82.2M last year, with margins expanding to 7.4% thanks to controlled costs despite rising professional fees. Diluted EPS of $0.52 matched basic, reconciling cleanly with 141.5M shares and no anti-dilution flags. Cash stood at $540.6M with $835.0M liquidity; free cash flow (derived) was $23.6M after $69.1M capex. Urgent care clinics closed January 2025 for $27.5M cash, adding goodwill. Yet regulatory shifts in Medicaid funding pose reimbursement risks.
8-K
Q2 revenue up 11.9%
Ardent Health posted Q2 revenue of $1.65 billion, up 11.9% year-over-year, with Adjusted EBITDA surging 38.9% to $170 million amid 6.6% admissions growth and 10.2% rise in net patient service revenue per adjusted admission. The New Mexico DPP renewal bolsters Medicaid support, while virtual nursing and AI tools enhance efficiency despite payor denials. Leverage improved to 2.7x. Five urgent care and two imaging centers open by year-end. Guidance reaffirmed at $6.2-6.45 billion revenue.
8-K
Schultz exits hospital ops role
Ardent Health, Inc. announced on June 16, 2025, that David Schultz stepped down as President, Hospital Operations, effective immediately, treated as a Qualifying Termination under the Executive Severance Plan. He qualifies for severance and benefits, detailed in prior SEC filings. This abrupt exit signals potential shifts in hospital leadership. Yet, details on a successor remain undisclosed.
8-K
Ardent Health name change effective
Ardent Health Partners, Inc. amended its Certificate of Incorporation on May 22, 2025, to change its name to Ardent Health, Inc., effective June 3, 2025, aligning its legal name with its longstanding brand usage. The update, approved by the board without needing stockholder vote, leaves the NYSE trading symbol ARDT and CUSIP unchanged, with no impact on stockholder rights. At the May 21 annual meeting, all 11 director nominees were elected and Ernst & Young LLP ratified as auditors. Name change streamlines identity; no operational shifts disclosed.
10-Q
Q1 FY2025 results
Ardent Health Partners kicked off 2025 with solid revenue growth, hitting $1.5B for Q1 ended March 31—up 4.0% y/y from $1.4B—fueled by 7.6% higher admissions and 2.3% more ER visits, though offset by a slight dip in surgeries. Profitability strengthened too, with operating income at $74.2M (up 31.1% y/y, derived) and diluted EPS rising to $0.29 from $0.21, reconciling neatly to 140.7M weighted shares; net income beat operating by $15.2M mainly from taxes and noncontrolling interests. Key drivers included favorable payor mix and supplemental funding, while supplies costs eased to 17.3% of revenue via supply chain tweaks. Liquidity holds firm at $495.0M cash and $295.1M revolver availability against $1.1B total debt (senior term loan at Term SOFR+2.75%, notes at 5.75% due 2029); free cash flow not disclosed in the 10-Q. On January 1, closed $27.5M all-cash acquisition of 18 urgent care clinics in New Mexico and Oklahoma, recognizing mostly goodwill with provisional intangibles. Yet regulatory shifts in Medicare and Medicaid reimbursement pose ongoing risks.
IPO
Website
Employees
Sector
Industry
ACHC
Acadia Healthcare Company, Inc.
23.01-0.16
AIRS
AirSculpt Technologies, Inc.
10.90-0.67
ASTH
Astrana Health Inc.
33.25-0.64
CYH
Community Health Systems, Inc.
4.21+0.09
HCA
HCA Healthcare, Inc.
468.40+1.94
NUTX
Nutex Health Inc.
127.83-0.85
PNTG
The Pennant Group, Inc.
25.03-0.86
SGRY
Surgery Partners, Inc.
22.76-0.18
THC
Tenet Healthcare Corporation
209.14+4.52
UHS
Universal Health Services, Inc.
225.30+5.98